These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
694 related articles for article (PubMed ID: 16195918)
1. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992 [TBL] [Abstract][Full Text] [Related]
3. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. Styren SD; Kamboh MI; DeKosky ST J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
5. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457 [TBL] [Abstract][Full Text] [Related]
6. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
7. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
9. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Fagan AM; Watson M; Parsadanian M; Bales KR; Paul SM; Holtzman DM Neurobiol Dis; 2002 Apr; 9(3):305-18. PubMed ID: 11950276 [TBL] [Abstract][Full Text] [Related]
10. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Gearing M; Mori H; Mirra SS Ann Neurol; 1996 Mar; 39(3):395-9. PubMed ID: 8602762 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539 [TBL] [Abstract][Full Text] [Related]
12. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Thal DR; Ghebremedhin E; Haass C; Schultz C Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Attems J; Jellinger KA; Lintner F Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541 [TBL] [Abstract][Full Text] [Related]
14. Activated microglia do not mediate the early deposition of Abeta in carriers of the apolipoprotein Eepsilon4 allele. Vogelgesang S; Schroeder E; Walker LC; Pahnke J; Naubereit A; Walther R; Stausske D; Warzok RW Clin Neuropathol; 2002; 21(3):99-106. PubMed ID: 12049183 [TBL] [Abstract][Full Text] [Related]
15. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Dolev I; Michaelson DM Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176 [TBL] [Abstract][Full Text] [Related]
16. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559 [TBL] [Abstract][Full Text] [Related]
17. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907 [TBL] [Abstract][Full Text] [Related]
18. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease. Bruinsma IB; te Riet L; Gevers T; ten Dam GB; van Kuppevelt TH; David G; Küsters B; de Waal RM; Verbeek MM Acta Neuropathol; 2010 Feb; 119(2):211-20. PubMed ID: 19636575 [TBL] [Abstract][Full Text] [Related]
19. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]